JACOB DAVIS: Open Payments
NPI 1255889903 · SHERMAN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$16,199 in 193 payments from 26 companies in 2025. Trend: 2023 $5,473 · 2024 $10,593 · 2025 $16,199
Speaker / faculty: $8,275Travel & lodging: $3,770Food & beverage: $3,343Consulting: $810
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 42 | $11,702 |
| Esperion Therapeutics, Inc. | 3 | $875 |
| Medtronic, Inc. | 10 | $872 |
| ABBVIE INC. | 60 | $658 |
| Senseonics, Incorporated | 1 | $400 |
| Bayer Healthcare Pharmaceuticals Inc. | 10 | $273 |
| Sequel Med Tech, LLC | 4 | $245 |
| AstraZeneca Pharmaceuticals LP | 6 | $154 |
| Antares Pharma, Inc. | 11 | $143 |
| Novo Nordisk Inc | 6 | $109 |
Products named: REPATHA, MINIMED 780G, NEXLIZET, Eversense, Kerendia, VRAYLAR, TWIIST, QULIPTA.
Industry payments across TX — which companies pay providers there.
